The safety and efficacy of SGLT2 inhibitors

SLGT2 Inhibitors

Since the SGLT-2 inhibitors have been launched there have been studies that have suggested potential concerns such as ketoacidosis and amputation and those that have demonstrated positive benefits on cardiovascular outcomes. This meta-analysis of the drugs may dispel the anxieties that some primary care clinicians have had over prescribing them.

http://jaha.ahajournals.org/content/7/2/e007165

Share

Related Articles

17th April 2020

Diagnosing respiratory symptoms over the phone

We have another excellent blog from one of our tutors Andrew Booth, a Respiratory Nurse Specialist working in a GP...

Read More

4th November 2011

WHO dunnit?

Should the World Health Organisation be abolished ? The reason I ask this question is all to do with diabetes and...

Read More

11th March 2020

COVID-19 Update 17 March

We are closely monitoring the situation with COVID-19, and are following Public Health England’s guidance for...

Read More